IL216875A0 - Determination of coronary artery disease risk - Google Patents
Determination of coronary artery disease riskInfo
- Publication number
- IL216875A0 IL216875A0 IL216875A IL21687511A IL216875A0 IL 216875 A0 IL216875 A0 IL 216875A0 IL 216875 A IL216875 A IL 216875A IL 21687511 A IL21687511 A IL 21687511A IL 216875 A0 IL216875 A0 IL 216875A0
- Authority
- IL
- Israel
- Prior art keywords
- determination
- coronary artery
- artery disease
- disease risk
- risk
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Data Mining & Analysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Databases & Information Systems (AREA)
- Analytical Chemistry (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Primary Health Care (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18720309P | 2009-06-15 | 2009-06-15 | |
| US24519009P | 2009-09-23 | 2009-09-23 | |
| PCT/US2010/038712 WO2010148017A1 (en) | 2009-06-15 | 2010-06-15 | Determination of coronary artery disease risk. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL216875A0 true IL216875A0 (en) | 2012-02-29 |
Family
ID=43356727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL216875A IL216875A0 (en) | 2009-06-15 | 2011-12-08 | Determination of coronary artery disease risk |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9122777B2 (en) |
| EP (1) | EP2443449B1 (en) |
| JP (1) | JP2012529914A (en) |
| KR (1) | KR20120046171A (en) |
| CN (1) | CN102803951A (en) |
| AU (1) | AU2010260152A1 (en) |
| BR (1) | BRPI1010693A2 (en) |
| CA (1) | CA2765145A1 (en) |
| DK (1) | DK2443449T3 (en) |
| EA (1) | EA201270020A1 (en) |
| IL (1) | IL216875A0 (en) |
| SG (2) | SG176692A1 (en) |
| WO (1) | WO2010148017A1 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2443449T3 (en) | 2009-06-15 | 2017-05-15 | Cardiodx Inc | DETERMINATION OF RISK OF CORONARY ARTERY DISEASE |
| KR101870123B1 (en) | 2010-07-09 | 2018-06-25 | 소마로직, 인크. | Lung cancer biomarkers and uses thereof |
| SG187045A1 (en) | 2010-08-13 | 2013-02-28 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof |
| WO2012094366A1 (en) * | 2011-01-06 | 2012-07-12 | Cardiodx, Inc. | Circulating mirnas as biomarkers for coronary artery disease |
| ES2777002T3 (en) * | 2011-09-30 | 2020-08-03 | Somalogic Inc | Prediction of cardiovascular risk events and uses of it |
| CN104101715A (en) * | 2014-07-15 | 2014-10-15 | 重庆医科大学附属儿童医院 | Kit for detecting DOCK8 (dedicator of cytokinesis 8) protein and non-diagnostic DOCK8 protein detection method |
| WO2016076899A1 (en) * | 2014-11-14 | 2016-05-19 | Medidata Solutions, Inc. | System and method for determining subject conditions in mobile health clinical trials |
| CN108135933B (en) | 2015-07-31 | 2022-04-29 | 脉管生物生长有限公司 | Motile sperm domain containing protein 2 and cancer |
| EP3328408B1 (en) * | 2015-07-31 | 2020-10-07 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 and inflammation |
| US20180356432A1 (en) * | 2015-09-01 | 2018-12-13 | Cardiodx, Inc. | Markers for coronary artery disease and uses thereof |
| US11056218B2 (en) | 2016-05-31 | 2021-07-06 | International Business Machines Corporation | Identifying personalized time-varying predictive patterns of risk factors |
| CN106327476A (en) * | 2016-08-25 | 2017-01-11 | 于洋 | CT image processing method and device |
| WO2018045079A1 (en) | 2016-09-01 | 2018-03-08 | The George Washington University | Blood rna biomarkers of coronary artery disease |
| US10832815B2 (en) | 2017-05-18 | 2020-11-10 | International Business Machines Corporation | Medical side effects tracking |
| CN107238712B (en) * | 2017-06-05 | 2018-12-28 | 中国人民解放军沈阳军区总医院 | Application of the blood plasma S100A12 in ST sections of elevation myocardial infarction prognosis |
| CN107271681A (en) * | 2017-06-05 | 2017-10-20 | 中国人民解放军沈阳军区总医院 | Applications of the blood plasma S100A12 in ST sections of elevation myocardial infarction early diagnosis |
| CN107292128A (en) * | 2017-06-27 | 2017-10-24 | 湖南农业大学 | One kind pairing interacting genes detection method and forecast model |
| CN107937521B (en) * | 2017-11-19 | 2019-01-04 | 武汉迈特维尔生物科技有限公司 | For detecting the kit of adrenocortical carcinoma |
| US20210217485A1 (en) * | 2018-01-15 | 2021-07-15 | Chang Gung Memorial Hospital, Linkou | Method of establishing a coronary artery disease prediction model for screening coronary artery disease |
| CN111354464B (en) * | 2018-12-24 | 2024-05-17 | 深圳先进技术研究院 | CAD prediction model establishment method and device and electronic equipment |
| CN111789949A (en) * | 2019-04-08 | 2020-10-20 | 北京昱嘉科技集团有限公司 | Alzheimer disease treatment target based on specific chemokine receptor |
| RU2740246C1 (en) * | 2020-03-20 | 2021-01-12 | Жанна Залкуфовна Отарова | Method for determining high risk of carotid atherosclerosis in rheumatoid arthritis |
| AU2021341888A1 (en) | 2020-09-10 | 2023-05-11 | Immunewalk Therapeutics, Inc. | Motile sperm domain containing protein 2 antibodies and methods of use thereof |
| CN112835316B (en) * | 2021-01-06 | 2022-04-19 | 重庆医科大学 | Neonatal sepsis shock prediction system and monitoring equipment |
| CN113295874B (en) * | 2021-05-25 | 2022-03-04 | 广东源心再生医学有限公司 | Novel marker for auxiliary diagnosis of valvular heart disease and auxiliary diagnosis product |
| CN113667739B (en) * | 2021-08-27 | 2023-12-26 | 河北医科大学第二医院 | Diagnostic marker combinations for coronary artery disease |
| CN113667740B (en) * | 2021-08-27 | 2023-12-26 | 河北医科大学第二医院 | Use of molecular marker combinations in diagnosing cardiovascular diseases |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020151479A1 (en) | 2000-01-31 | 2002-10-17 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US20030099958A1 (en) | 2001-09-05 | 2003-05-29 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
| US20050032066A1 (en) | 2003-08-04 | 2005-02-10 | Heng Chew Kiat | Method for assessing risk of diseases with multiple contributing factors |
| US20070218513A1 (en) | 2003-10-16 | 2007-09-20 | Novartis Ag | Differentially Expressed Genes Related to Coronary Artery Disease |
| US20070238124A1 (en) | 2003-10-16 | 2007-10-11 | Chibout Salah D | Differentially expressed genes related to coronary artery disease |
| WO2005103720A1 (en) | 2004-03-29 | 2005-11-03 | Medstar Research Institute, Inc. | Methods of diagnosing cardiovascular disease |
| CA2612021A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20070015170A1 (en) | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
| US20100035963A1 (en) | 2005-09-09 | 2010-02-11 | Ayelet Chajut | Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease |
| EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| WO2008080126A2 (en) * | 2006-12-22 | 2008-07-03 | Aviir, Inc. | Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| JP5646179B2 (en) * | 2007-02-21 | 2014-12-24 | デコード・ジェネティクス・イーエイチエフ | Genetic susceptibility variants associated with cardiovascular disease |
| US7695916B2 (en) | 2007-03-22 | 2010-04-13 | Celera Corporation | Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
| DK2155907T3 (en) | 2007-04-30 | 2015-08-31 | Decode Genetics Ehf | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction |
| WO2009049257A2 (en) | 2007-10-11 | 2009-04-16 | Cardio Dx, Inc. | Predictive models and methods for diagnosing and assessing coronary artery disease |
| WO2010038104A1 (en) | 2008-10-03 | 2010-04-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combination of cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event. |
| DK2443449T3 (en) | 2009-06-15 | 2017-05-15 | Cardiodx Inc | DETERMINATION OF RISK OF CORONARY ARTERY DISEASE |
-
2010
- 2010-06-15 DK DK10790073.0T patent/DK2443449T3/en active
- 2010-06-15 JP JP2012516212A patent/JP2012529914A/en active Pending
- 2010-06-15 SG SG2011090107A patent/SG176692A1/en unknown
- 2010-06-15 EA EA201270020A patent/EA201270020A1/en unknown
- 2010-06-15 AU AU2010260152A patent/AU2010260152A1/en not_active Abandoned
- 2010-06-15 KR KR1020127001127A patent/KR20120046171A/en not_active Application Discontinuation
- 2010-06-15 CN CN201080036171XA patent/CN102803951A/en active Pending
- 2010-06-15 US US12/816,232 patent/US9122777B2/en not_active Expired - Fee Related
- 2010-06-15 BR BRPI1010693A patent/BRPI1010693A2/en not_active IP Right Cessation
- 2010-06-15 WO PCT/US2010/038712 patent/WO2010148017A1/en active Application Filing
- 2010-06-15 SG SG10201403152QA patent/SG10201403152QA/en unknown
- 2010-06-15 CA CA2765145A patent/CA2765145A1/en not_active Abandoned
- 2010-06-15 EP EP10790073.0A patent/EP2443449B1/en not_active Not-in-force
-
2011
- 2011-12-08 IL IL216875A patent/IL216875A0/en unknown
-
2014
- 2014-01-16 US US14/157,196 patent/US8914240B2/en not_active Expired - Fee Related
-
2015
- 2015-07-17 US US14/802,544 patent/US20150315652A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120046171A (en) | 2012-05-09 |
| AU2010260152A1 (en) | 2012-02-02 |
| EP2443449B1 (en) | 2017-04-12 |
| CA2765145A1 (en) | 2010-12-23 |
| JP2012529914A (en) | 2012-11-29 |
| EA201270020A1 (en) | 2012-07-30 |
| US20140156198A1 (en) | 2014-06-05 |
| EP2443449A1 (en) | 2012-04-25 |
| SG176692A1 (en) | 2012-01-30 |
| WO2010148017A1 (en) | 2010-12-23 |
| US8914240B2 (en) | 2014-12-16 |
| DK2443449T3 (en) | 2017-05-15 |
| US20150315652A1 (en) | 2015-11-05 |
| US9122777B2 (en) | 2015-09-01 |
| US20110015865A1 (en) | 2011-01-20 |
| EP2443449A4 (en) | 2012-12-26 |
| CN102803951A (en) | 2012-11-28 |
| SG10201403152QA (en) | 2014-08-28 |
| BRPI1010693A2 (en) | 2019-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL216875A0 (en) | Determination of coronary artery disease risk | |
| EP2498796A4 (en) | Treatment of heart disease | |
| EP2405806A4 (en) | Predicting coronary artery disease and risk of cardiovascular events | |
| GB2473392B (en) | Methods of diagnosis | |
| EP2393914A4 (en) | Tissue engineering of lung | |
| IL219859A0 (en) | Method and apparatus to detect coronary artery calcification or disease | |
| PL2464408T3 (en) | Catheter instrument | |
| IL209855A0 (en) | Supression of neuroedocrine diseases | |
| EP2397139A4 (en) | Anti-neurodegenerative disease agent | |
| GB0908193D0 (en) | Treatment of disease state | |
| GB2467840B (en) | Disease determination | |
| IL207075A0 (en) | Generic markers of mental illness | |
| GB0814533D0 (en) | Measurement of bio-signals | |
| EP2375957C0 (en) | Pre-rinsing of dishes | |
| HK1138750A1 (en) | Processing of biosignal | |
| IL210922A0 (en) | Treatment of pulmonary arterial hypertension | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| EP2451347A4 (en) | Non-invasively measuring physiological process | |
| IL255052A0 (en) | Treatment of inflammatory bowel disease with 6-mercaptopurine | |
| GB0720976D0 (en) | Treatment of inflammatory disease | |
| SI2491005T1 (en) | Use of 4-šethyl(dimethyl)ammonioćbutanoate in the treatment of cardiovascular disease | |
| ZA201003867B (en) | Treatment of heart disease using b-blockers | |
| GB0903858D0 (en) | Diagnosis of disease | |
| GB0902736D0 (en) | Novel biomarkers of vascular disease | |
| GB0908666D0 (en) | Treatment of proteostatic disease |